Ariad Pharmaceuticals
US-based Ariad Pharmaceuticals is focused on discovering, developing and commercializing precision therapies for patients with rare cancers.
Ariad is working on new medicines to advance the treatment of rare forms of chronic and acute leukemia, lung and other cancers.
The company utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines.
Latest Ariad Pharmaceuticals News & Features
9 January 2017
29 September 2016
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze